Senate reauthorizes FDA to collect fees from drugmakers(Reuters) - The U.S. Senate on Thursday passed a bill allowing the Food and Drug Administration to continue collecting fees from drug companies to review new product applications. The FDA Reauthorization Act renews an existing law that expires on Sept. 30 and which provides the majority of FDA funds used to review pharmaceuticals and determine whether they are safe and effective. The Senate passed the bill by a vote of 94-1. It was passed last month in the House of Representatives. Separately, the Senate passed a so-called right-to-try bill designed to allow terminally ill patients access to unapproved medications and to provide immunity for physicians willing to administer the treatments. The House has not yet passed that bill. politicsNews
senate authorizes fda collect fees drugmakers reuters the senate thursday passed bill allowing food drug administration continue collecting fees drug companies review new product applications the fda authorization act renews existing law expires provides majority fda funds used review pharmaceuticals determine whether safe effective the senate passed bill vote it passed last month house representatives separately senate passed bill designed allow terminally ill patients access unapproved medications provide immunity physicians willing administer treatments the house yet passed bill politicsnews
Your task is to classify the provided input as real or fake news. Label 0 is meant for fake news, Label 1 is for real news. TEXT: Senate reauthorizes FDA to collect fees from drugmakers(Reuters) - The U.S. Senate on Thursday passed a bill allowing the Food and Drug Administration to continue collecting fees from drug companies to review new product applications. The FDA Reauthorization Act renews an existing law that expires on Sept. 30 and which provides the majority of FDA funds used to review pharmaceuticals and determine whether they are safe and effective. The Senate passed the bill by a vote of 94-1. It was passed last month in the House of Representatives. Separately, the Senate passed a so-called right-to-try bill designed to allow terminally ill patients access to unapproved medications and to provide immunity for physicians willing to administer the treatments. The House has not yet passed that bill. politicsNews
Your task is to classify the provided input as real or fake news. Label 0 is meant for fake news, Label 1 is for real news. TEXT: senate authorizes fda collect fees drugmakers reuters the senate thursday passed bill allowing food drug administration continue collecting fees drug companies review new product applications the fda authorization act renews existing law expires provides majority fda funds used review pharmaceuticals determine whether safe effective the senate passed bill vote it passed last month house representatives separately senate passed bill designed allow terminally ill patients access unapproved medications provide immunity physicians willing administer treatments the house yet passed bill politicsnews